Pediatric Clinics of North America - CIPERJ
Pediatric Clinics of North America - CIPERJ
Pediatric Clinics of North America - CIPERJ
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
PARTIAL SPLENECTOMY FOR HEREDITARY SPHEROCYTOSIS<br />
511<br />
Similarly, Soyer and colleagues [47] demonstrated an elevated rate <strong>of</strong> thrombosis<br />
in a cohort <strong>of</strong> children who had hematologic conditions and were<br />
undergoing splenectomy. At this time, it is unclear whether or not there is<br />
a decreased risk for thrombosis after partial splenectomy compared with<br />
the risk noted after total splenectomy. A demonstrable risk reduction for<br />
thrombosis would further support the use <strong>of</strong> partial splenectomy not only<br />
for children who have HS but also in other common conditions requiring<br />
splenic resection.<br />
Clinical studies <strong>of</strong> partial splenectomy in hereditary spherocytosis<br />
For children who have HS, the role <strong>of</strong> partial splenectomy has been<br />
evaluated in several nonrandomized clinical studies in Europe and <strong>North</strong><br />
<strong>America</strong> [7,13,48]. The following section summarizes the experience gained<br />
to date [7,13,14,16,48–51].<br />
French experience<br />
The resurgence <strong>of</strong> and recent interest in using partial splenectomy was<br />
stimulated by Tchernia and colleagues from the Hoˆ pital Bice` tre in Paris,<br />
France [2,7,13]. This group advocates an 80% to 90% partial splenectomy<br />
in children who have HS. In their most recent summary, 40 children who<br />
had HS and underwent partial splenectomy were monitored for 1 to 14<br />
years. In this nonrandomized trial, partial splenectomy resulted in a sustained<br />
decrease in hemolytic anemia with a significantly increased hemoglobin<br />
concentration, which improved from 9.2 2.6 g/dL at baseline to 12.3 <br />
1.9 g/dL at 3 to 4 years after surgery (P!.01). The increased hemoglobin<br />
concentration was maintained for up to 10 years after surgery.<br />
This group also demonstrated preserved phagocytic function <strong>of</strong> the<br />
splenic remnant using radionuclide liver-spleen imaging in most children.<br />
Furthermore, they demonstrated in a subset <strong>of</strong> children an increased red<br />
cell lifespan averaging 6.5 days (range: 5 to 14.5 days). Tchernia and colleagues<br />
[2,7,13] have shown that partial splenectomy does not abolish the<br />
risk for aplastic crisis or the formation <strong>of</strong> gallstones, documenting that<br />
a moderate degree <strong>of</strong> hemolysis persists in some children. Furthermore,<br />
they have shown that the remnant spleen grew in some patients, although<br />
there was no clear correlation between splenic regrowth and recurrent hemolytic<br />
anemia. The authors have made this same fascinating observation.<br />
In addition to the French group, a group in the Czech Republic recently<br />
published their initial experience with a cohort <strong>of</strong> 14 children who had HS<br />
and were undergoing partial splenectomy by a similar technique to that used<br />
by Tchernia. In this nonrandomized study, the mean hemoglobin concentration<br />
increased from 9.9 to 13.8 g/dL [52]. After 5 years <strong>of</strong> follow-up, no child<br />
required late conversion to total splenectomy.